文献速递骨质疏松与钙磷/甲状旁腺性腺与生殖内分泌

SHBG、骨密度与躯体功能在伴或不伴HIV及HCV的注射吸毒者中的关联

SHBG, Bone Mineral Density, and Physical Function Among Injection Drug Users With and Without HIV and HCV.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

这项横断面研究纳入278名HCV暴露成人,按HIV/HCV状态分4组,评估SHBG与骨密度及躯体功能的关联。女性中较高SHBG与握力较低、衰弱 odds 较高及腰椎T值较低相关,男性中未见类似关联。HIV RNA>400 copies/mL和HCV RNA>15 IU/mL者SHBG较高。

要点

  • 女性中SHBG每升高10 nmol/L,握力降低0.43 kg,衰弱 odds 增加49%,腰椎T值降低0.070 SD。
  • 男性中未观察到SHBG与握力、衰弱或骨密度的类似关联。
  • HIV RNA>400 copies/mL(P=.02)和HCV RNA>15 IU/mL(P<.001)者SHBG浓度较高。

核心结论

  • 较高SHBG浓度与HIV和HCV病毒血症存在相关;在女性而非男性中,较高SHBG与较低握力、较高衰弱 odds 及较低腰椎骨密度相关;这些关联的机制需进一步研究。

研究设计与样本

  • 横断面研究,纳入AIDS Linked to the IntraVenous Experience队列中278名HCV暴露(HCV抗体阳性)成人,按HIV/HCV状态分为HCV-/HIV-、HCV-/HIV+、HCV+/HIV-和HCV+/HIV+四组。

主要发现

  • 女性中较高SHBG与较低握力相关(-0.43 [95% CI, -0.77至-0.081] kg/10 nmol/L,P<.05)。
  • 女性中较高SHBG与较高衰弱 odds 相关(odds ratio 1.49 [95% CI, 1.07至2.08],P<.05)。
  • 女性中较高SHBG与较低腰椎T值相关(-0.070 [95% CI, -0.15至-0.001] SD/10 nmol/L T-score BMD,P<.05)。
  • 男性中未观察到上述类似关联。
  • HIV RNA大于400 copies/mL者SHBG浓度较高(P=.02),HCV RNA大于15 IU/mL者SHBG浓度较高(P<.001)。

关键数值与推荐

  • 女性中SHBG每升高10 nmol/L,握力降低0.43 kg(95% CI, -0.77至-0.081),P<.05。
  • 女性中SHBG每升高10 nmol/L,衰弱 odds ratio 为1.49(95% CI, 1.07至2.08),P<.05。
  • 女性中SHBG每升高10 nmol/L,腰椎T值降低0.070 SD(95% CI, -0.15至-0.001),P<.05。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性;作者在结论中写明这些关联的潜在机制需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Sex hormone-binding globulin (SHBG) is a glycoprotein that regulates the bioavailability of sex hormones and is higher in people with HIV (PWH) and hepatitis C virus (HCV). SHBG is associated with aging-related diseases, including osteoporosis and frailty in the general population. However, the relationship between SHBG concentration and bone mineral density (BMD) and physical function among PWH and HCV is unclear. OBJECTIVE: This study aimed to evaluate the association between chronic infection with HIV and HCV and SHBG, and to assess the relationship of circulating SHBG concentrations with low BMD, physical function impairment, and frailty. METHODS: A cross-sectional study was conducted of 278 HCV-exposed (HCV antibody positive) adults enrolled with and without HIV and HCV from the AIDS Linked to the IntraVenous Experience cohort study into 4 groups: HCV-/HIV-, HCV-/HIV+, HCV+/HIV-, and HCV+/HIV+. We evaluated the association between SHBG concentrations and grip strength, gait speed, Short Physical Performance Battery score, frailty (Fried Frailty Phenotype), and BMD (lumbar spine, total hip, and femoral neck T-score) by using adjusted multivariable regression stratified by sex. RESULTS: SHBG concentrations were higher in women, in those with HIV RNA greater than 400 copies/mL (P = .02) and HCV RNA greater than 15 IU/mL (P < .001). In adjusted models, higher SHBG concentrations among women were statistically significantly associated with lower grip strength (-0.43 [95% CI, -0.77 to -0.081] kg/10 nmol/L, P < .05), higher odds of frailty (odds ratio, 1.49 [95% CI, 1.07 to 2.08], P < .05), and lower T-scores at the lumbar spine (-0.070 [95% CI, -0.15 to -0.001] SD/10 nmol/L T-score BMD, P < .05). Similar associations were not observed among men. CONCLUSION: Higher SHBG concentrations are associated with the presence of HIV and HCV viremia. Among women, but not men, higher SHBG concentrations were associated with lower grip strength, higher odds of frailty, and lower lumbar spine BMD. The underlying mechanisms of these associations require further investigation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Dias JP, Piggott DA, Sun J, et al. SHBG, Bone Mineral Density, and Physical Function Among Injection Drug Users With and Without HIV and HCV. J Clin Endocrinol Metab. 2022. PMID: 35293996. doi:10.1210/clinem/dgac144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。